Ad
related to: how did moderna get started in ohio- Long COVID-19 Data
Get Info About Long COVID
From The Moderna HCP Site
- COVID-19 Provider Info
HCPs: Get Current
Data About COVID-19
- Long COVID-19 Data
Search results
Results From The WOW.Com Content Network
Moderna was founded in 2010 by Derrick Rossi, Timothy A. Springer, Kenneth R. Chien, Robert S. Langer, and Noubar Afeyan. [9] Stéphane Bancel , the current CEO, was appointed as CEO in 2011. [ 6 ] [ 10 ] Between 2011 and 2017, Moderna raised $2 billion in venture capital funding.
In January 2021, Moderna started development of a new form of its vaccine, called mRNA-1273.351, that could be used as a booster shot against the Beta variant (lineage B.1.351). [ 195 ] [ 186 ] In February 2021, Moderna announced that it had manufactured and shipped sufficient amounts of mRNA-1273.351 to the National Institutes of Health to run ...
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
For the average person, the first time the biotech startup Moderna landed on their radar was within the last year, as the company became a leading contender in the production of COVID-19 vaccines ...
In March 2021, the CHMP started a rolling review of Sputnik V (Gam-COVID-Vac). [165] The EU applicant is R-Pharm Germany GmbH. [165] In May 2021, the CMMP started evaluating the use of Comirnaty to include young people aged 12 to 15, [166] and it started a rolling review of Sinovac COVID-19 Vaccine. [167] The EU applicant for Sinovac is Life'On ...
Moderna is on its way to getting a third mRNA-based vaccine approved by the FDA if the regulatory agency likes the data released Monday for a combination flu-COVID shot.The company said the new ...
An advisory committee meeting is scheduled on Dec 17 to discuss emergency use authorization for Moderna's (MRNA) COVID-19 vaccine candidate, mRNA-1273.
Noubar Afeyan (Western Armenian: Նուպար Աֆէեան; born in 1962) is an American-Canadian entrepreneur, inventor, and philanthropist. [1] [2] He is best known for co-founding the biotechnology company Moderna, through his venture capital firm, Flagship Pioneering, and for co-founding humanitarian projects such as Aurora Prize and The Future Armenian.